Next big COVID-19 treatment may be manufactured antibodies

Aug 04, 2020

Development of monoclonal antibodies to target the virus has been endorsed by leading scientists. Scientists are still working out the exact role of neutralizing antibodies in recovery from COVID-19, but drugmakers are confident that the right antibodies or a combination can alter the course of the disease. Reuters


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?